AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Non Operating Income (2020 - 2026)

AtaiBeckley (ATAI) posted quarterly Non Operating Income of $1.1 million for Q1 2026, up 118.84% year-over-year from $511328.8 in Q1 2025, and up 118.84% quarter-over-quarter from -$5.9 million in Q1 2025.

Analysis

AtaiBeckley (ATAI) Non Operating Income (2020 - 2026) Analysis & Trends

AtaiBeckley has reported Non Operating Income for 6 years, with the latest figure at -$32.5 million in Q3 2025.

  • Quarterly Non Operating Income fell 742.55% year-over-year to -$32.5 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$49.8 million (down 130.8% YoY) and the FY2024 annual result came in at -$45.7 million, down 153.04% from the prior year.
  • Non Operating Income for Q1 2026 stood at $1.1 million, up from -$5.9 million in the prior quarter.
  • The five-year high for Non Operating Income was $1.1 million in Q1 2026, with the low at -$5.9 million in Q1 2025.
  • A 5-year average of $443105.3 and a median of -$1.6 million in 2024 frame the typical range for Non Operating Income.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Income soared 1236.38% in 2023, then slumped 15466.67% in 2024.
  • Over 5 years, Non Operating Income stood at -$3.4 million in 2021, then jumped by 48.41% to -$1.8 million in 2022, then surged by 967.94% to $15.2 million in 2023, then tumbled by 158.52% to -$8.9 million in 2024, then tumbled by 264.74% to -$32.5 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$32.5 million, -$2.4 million, and -$5.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -139.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -51.63 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 AtaiBeckley 1.61 Bn 1.61 Bn - -32.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.66 Mn
Mar 31, 2026 1.12 Mn
Sep 30, 2025 -32.53 Mn
Jun 30, 2025 -2.38 Mn
Jun 30, 2025 -2.38 Mn
Mar 31, 2025 -5.94 Mn
Mar 31, 2025 -5.94 Mn
Dec 31, 2024 -8.92 Mn
Sep 30, 2024 -3.86 Mn
Jun 30, 2024 -31.35 Mn
Mar 31, 2024 -1.60 Mn
Dec 31, 2023 15.24 Mn
Sep 30, 2023 70.68 Mn
Jun 30, 2023 204,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 -1.76 Mn
Sep 30, 2022 5.29 Mn
Jun 30, 2022 4.55 Mn
Mar 31, 2022 1.52 Mn
Dec 31, 2021 -3.40 Mn